Digene gets FDA yes on HPV (Human Papilloma Virus) test, but with reservations
This article was originally published in Clinica
Executive Summary
An FDA advisory committee decision recommending that the agency approve the expanded use of Digene's DNA Pap test may not be as positive for the company as it seems, Clinica has learned. Early this month, the microbiology devices panel voted 6-2 on a motion that the company's Hybrid Capture 2 High-Risk HPV DNA test be approvable with conditions.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.